{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:44:06Z","timestamp":1757612646688,"version":"3.44.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013221","name":"Razi Vaccine and Serum Research Institute","doi-asserted-by":"publisher","award":["2-18-18-93120"],"award-info":[{"award-number":["2-18-18-93120"]}],"id":[{"id":"10.13039\/501100013221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11626-025-01069-4","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:06:44Z","timestamp":1751468804000},"page":"862-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-animal testing of Iranian enterotoxemia vaccine: cell culture assay for Clostridium perfringens epsilon toxin"],"prefix":"10.1007","volume":"61","author":[{"given":"Anahita","family":"Emadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida Abdolmohammadi","family":"Khiav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faranak","family":"Abnaroodheleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Dadar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"1069_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11250-021-02728-w","volume":"53","author":"L Abdolmohammadi Khiav","year":"2021","unstructured":"Abdolmohammadi Khiav L, Zahmatkesh A (2021) Vaccination against pathogenic clostridia in animals: a review. Trop Anim Health Prod 53:284","journal-title":"Trop Anim Health Prod"},{"key":"1069_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.35864\/evmd.1192288","volume":"34","author":"A Arslan","year":"2023","unstructured":"Arslan A, Erba\u015f G (2023) Determining the potency of vaccines containing Clostridium perfringens epsilon toxoid via toxicity analysis in MDCK cell lines. Etlik Veteriner Mikrobiyoloji Dergisi 34:59\u201366","journal-title":"Etlik Veteriner Mikrobiyoloji Dergisi"},{"key":"1069_CR3","doi-asserted-by":"publisher","first-page":"100305","DOI":"10.1016\/j.vas.2023.100305","volume":"21","author":"A Asadi","year":"2023","unstructured":"Asadi A, Khiav LA, Emadi A, Dadar M (2023) Evaluation of humoral immune responses against C. perfringens epsilon toxin in Iranian sheep and goats after vaccination. Veterinary and Animal Science 21:100305","journal-title":"Veterinary and Animal Science"},{"key":"1069_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1574-695X.2001.tb00503.x","volume":"31","author":"E Borrmann","year":"2001","unstructured":"Borrmann E, G\u00fcnther H, K\u00f6hler H (2001) Effect of Clostridium perfringens epsilon toxin on MDCK cells. FEMS Immunol Med Microbiol 31:85\u201392","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1069_CR5","first-page":"30","volume":"9","author":"E Borrmann","year":"1997","unstructured":"Borrmann E, Schulze F (1997) Use of cell culture assays for potency testing of C. perfringens immunobiologicals as an alternative to mouse toxin neutralisation test. Pharmeuropa-English Edition- 9:30\u201339","journal-title":"Pharmeuropa-English Edition-"},{"key":"1069_CR6","first-page":"275","volume":"24","author":"E Borrmann","year":"1999","unstructured":"Borrmann E, Schulze F (1999) Detection of Clostridium novyi type B \u03b1 toxin by cell culture systems. FEMS Immunol Med Microbiol 24:275\u2013280","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1069_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.vetmic.2005.10.043","volume":"114","author":"E Borrmann","year":"2006","unstructured":"Borrmann E, Schulze F, Cussler K, H\u00e4nel I, Diller R (2006) Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin. Vet Microbiol 114:41\u201350","journal-title":"Vet Microbiol"},{"key":"1069_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1099\/00222615-11-3-299","volume":"11","author":"D Buxton","year":"1978","unstructured":"Buxton D (1978) In-vitro effects of Clostridium welchii type-D epsilon toxin on guinea-pig, mouse, rabbit and sheep cells. J Med Microbiol 11:299\u2013302","journal-title":"J Med Microbiol"},{"key":"1069_CR9","first-page":"832","volume":"13","author":"R Chehreara","year":"2021","unstructured":"Chehreara R, Karizi SZ, Hosseini HM, Mirhosseini SA, Shafiei M, Amani J, Kazemi R (2021) Cell death analysis of recombinant mature epsilon toxin on the kidney cell line. Iranian Journal of Microbiology 13:832","journal-title":"Iranian Journal of Microbiology"},{"key":"1069_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10091473","volume":"10","author":"CY Cheung","year":"2022","unstructured":"Cheung CY, Dubey S, Hadrovic M, Ball CR, Ramage W, McDonald JU, Harvey R, Hufton SE, Engelhardt OG (2022) Development of an ELISA-based potency assay for inactivated influenza vaccines using cross-reactive nanobodies. Vaccines 10:1473","journal-title":"Vaccines"},{"key":"1069_CR11","first-page":"522","volume":"7","author":"J Craig","year":"1966","unstructured":"Craig J (1966) Enterotoxaemia (pulpy kidney disease). Journal of the Department of Agriculture, Western Australia, Series 7:522\u2013526","journal-title":"Journal of the Department of Agriculture, Western Australia, Series"},{"key":"1069_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102398","volume":"85","author":"JW Crothers","year":"2023","unstructured":"Crothers JW, Norton EB (2023) Recent advances in enterotoxin vaccine adjuvants. Curr Opin Immunol 85:102398","journal-title":"Curr Opin Immunol"},{"key":"1069_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.provac.2011.10.016","volume":"5","author":"H Draayer","year":"2011","unstructured":"Draayer H (2011) Overview of currently approved veterinary vaccine potency testing methods and methods in development that do not require animal use. Procedia in Vaccinology 5:171\u2013174","journal-title":"Procedia in Vaccinology"},{"key":"1069_CR14","doi-asserted-by":"publisher","first-page":"108365","DOI":"10.1016\/j.toxicon.2025.108365","volume":"260","author":"P Esmaeilnejad-Ahranjani","year":"2025","unstructured":"Esmaeilnejad-Ahranjani P, Shahali Y, Dadar M (2025) Detoxification techniques for bacterial toxins: a pathway to effective toxoid vaccines. Toxicon 260:108365. https:\/\/doi.org\/10.1016\/j.toxicon.2025.108365","journal-title":"Toxicon"},{"key":"1069_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140321","volume":"10","author":"C Gil","year":"2015","unstructured":"Gil C, Dorca-Ar\u00e9valo J, Blasi J (2015) Clostridium perfringens epsilon toxin binds to membrane lipids and its cytotoxic action depends on sulfatide. PLoS ONE 10:e0140321","journal-title":"PLoS ONE"},{"key":"1069_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1099\/00222615-16-2-233","volume":"16","author":"L Giugliano","year":"1983","unstructured":"Giugliano L, Stringer M, Drasar B (1983) Detection of Clostridium perfringens enterotoxin by tissue culture and double-gel diffusion methods. J Med Microbiol 16:233\u2013237","journal-title":"J Med Microbiol"},{"key":"1069_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1373411","volume":"15","author":"M Hoonakker","year":"2024","unstructured":"Hoonakker M, Zariri A, De Brouwer L, David D, Borgman A, Sloots A (2024) An in vitro assay for toxicity testing of Clostridium perfringens type C \u03b2-toxin. Front Immunol 15:1373411","journal-title":"Front Immunol"},{"key":"1069_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2021.106395","volume":"193","author":"LA Khiav","year":"2022","unstructured":"Khiav LA, Emadi A, Zahmatkesh A (2022) A simple method for purification of epsilon toxin of Clostridium perfringens type D for serum neutralization assay. J Microbiol Methods 193:106395","journal-title":"J Microbiol Methods"},{"key":"1069_CR19","first-page":"129","volume":"64","author":"P Knight","year":"1986","unstructured":"Knight P, Burnett C, Whitaker A, Queminet J (1986) The titration of clostridial toxoids and antisera in cell culture. Dev Biol Stand 64:129\u2013136","journal-title":"Dev Biol Stand"},{"key":"1069_CR20","doi-asserted-by":"crossref","unstructured":"Knight P, Queminet J, Blanchard J, Tilleray J (1990) In vitro tests for the measurement of clostridial toxins, toxoids and antisera: II. titration of Clostridium perfringens toxins and antitoxins in cell culture. Biologicals 18:263\u2013270","DOI":"10.1016\/1045-1056(90)90028-X"},{"key":"1069_CR21","first-page":"12","volume":"2018","author":"C Lang","year":"2018","unstructured":"Lang C, Kolaj-Robin O, Cirefice G, Taconet L, Pel E, Jouette S, Buda M, Milne C, Charton E (2018) Replacement, reduction, refinement-animal welfare progress in European Pharmacopoeia monographs: activities of the European Pharmacopoeia Commission from 2007 to 2017. Pharmeur Bio Sci Notes 2018:12\u201336","journal-title":"Pharmeur Bio Sci Notes"},{"key":"1069_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2022.11.002","volume":"81","author":"E Lilley","year":"2023","unstructured":"Lilley E, Coppens E, Das P, Galaway F, Isbrucker R, Sheridan S, Stickings P, Holmes A (2023) Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: responses from a survey of vaccines and biological therapeutics manufacturers. Biologicals 81:101660","journal-title":"Biologicals"},{"key":"1069_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1590\/1808-1657v78p5072011","volume":"78","author":"C Lima","year":"2020","unstructured":"Lima C, Lobato Z, Pires P, Silva R, Salvarani F, Assis R, Lobato F (2020) Padroniza\u00e7\u00e3o de teste de pot\u00eancia in vitro para vacinas que contenham toxoide alfa de Clostridium novyi tipo B. Arq Inst Biol (Sao Paulo) 78:507\u2013512","journal-title":"Arq Inst Biol (Sao Paulo)"},{"key":"1069_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/096032719601501107","volume":"15","author":"CD Lindsay","year":"1996","unstructured":"Lindsay CD (1996) Assessment of aspects of the toxicity of Clostridium perfringens E-toxin using the MDCK cell line. Hum Exp Toxicol 15:904\u2013908","journal-title":"Hum Exp Toxicol"},{"key":"1069_CR25","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1016\/j.vaccine.2010.07.046","volume":"28","author":"FC Lobato","year":"2010","unstructured":"Lobato FC, Lima CG, Assis RA, Pires PS, Silva RO, Salvarani FM, Carmo AO, Contigli C, Kalapothakis E (2010) Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants. Vaccine 28:6125\u20136127","journal-title":"Vaccine"},{"key":"1069_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144999","volume":"759","author":"R Luo","year":"2020","unstructured":"Luo R, Yang Q, Huang X, Yan Z, Gao X, Wang W, Xie K, Wang P, Gun S (2020) Clostridium perfringens beta2 toxin induced in vitro oxidative damage and its toxic assessment in porcine small intestinal epithelial cell lines. Gene 759:144999","journal-title":"Gene"},{"key":"1069_CR27","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/S2666-5247(23)00001-0","volume":"4","author":"A Marzi","year":"2023","unstructured":"Marzi A, Fletcher P, Feldmann F, Saturday G, Hanley PW, Feldmann H (2023) Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques. The Lancet Microbe 4:e171\u2013e178","journal-title":"The Lancet Microbe"},{"key":"1069_CR28","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/S0264-410X(02)00192-5","volume":"20","author":"B Metz","year":"2002","unstructured":"Metz B, Hendriksen CF, Jiskoot W, Kersten GF (2002) Reduction of animal use in human vaccine quality control: opportunities and problems. Vaccine 20:2411\u20132430","journal-title":"Vaccine"},{"key":"1069_CR29","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1128\/iai.60.3.1237-1240.1992","volume":"60","author":"M Nagahama","year":"1992","unstructured":"Nagahama M, Sakurai J (1992) High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain. Infect Immun 60:1237\u20131240","journal-title":"Infect Immun"},{"key":"1069_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1574-6968.1994.tb06695.x","volume":"116","author":"DW Payne","year":"1994","unstructured":"Payne DW, Williamson ED, Havard H, Modi N, Brown J (1994) Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin. FEMS Microbiol Lett 116:161\u2013167","journal-title":"FEMS Microbiol Lett"},{"key":"1069_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27:493\u2013497","journal-title":"Am J Epidemiol"},{"key":"1069_CR32","first-page":"65","volume":"21","author":"U Rosskopf-Streicher","year":"2004","unstructured":"Rosskopf-Streicher U, Volkers P, Noeske K, Werner E (2004) Quality assurance of C. perfringens epsilon toxoid vaccines-ELISA versus mouse neutralisation test. Altex-Alternatives to Animal Experimentation 21:65\u201369","journal-title":"Altex-Alternatives to Animal Experimentation"},{"key":"1069_CR33","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1590\/S0102-09352010000400002","volume":"62","author":"F Salvarani","year":"2010","unstructured":"Salvarani F, Lobato Z, Assis R, Lima C, Silva R, Pires P, Lobato F (2010a) In vitro evaluation of Clostridium septicum alpha toxoid. Arq Bras Med Vet Zootec 62:778\u2013783","journal-title":"Arq Bras Med Vet Zootec"},{"key":"1069_CR34","doi-asserted-by":"crossref","unstructured":"Salvarani F, Lobato Z, Assis R, Lima C, Silva R, Pires P, Lobato F (2010b) In vitro evaluation of the alpha toxoid from Clostridium septicum. Arq Bras Med Vet Zootec 62:778\u2013783","DOI":"10.1590\/S0102-09352010000400002"},{"key":"1069_CR35","doi-asserted-by":"crossref","unstructured":"Salvarini FM, Lobato ZIP, Pires PS, Silva ROS, Alves GG, Pereira PLL, Lobato FCF (2013) In vitro potency test for evaluation of Clostridium perfringens type D epsilon toxoid. Arq Inst Biol (Sao Paulo) 80:450\u2013452","DOI":"10.1590\/S1808-16572013000400013"},{"key":"1069_CR36","unstructured":"Sebald M, Petit J-C (1997) Laboratory methods: anaerobic bacteria and their identification (M\u00e9thodes de laboratoire: Bact\u00e9ries ana\u00e9robies et leur identification). Paris: Institut Pasteur"},{"key":"1069_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10254-004-0036-2","volume":"152","author":"J Smedley","year":"2005","unstructured":"Smedley J, Fisher D, Sayeed S, Chakrabarti G, McClane B (2005) The enteric toxins of Clostridium perfringens. Rev Physiol, BiochemiPharmacol 152:183\u2013204. https:\/\/doi.org\/10.1007\/s10254-004-0036-2","journal-title":"Rev Physiol, BiochemiPharmacol"},{"key":"1069_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1369\/jhc.4A6254.2004","volume":"52","author":"A Soler-Jover","year":"2004","unstructured":"Soler-Jover A, Blasi J, de Aranda IG, Navarro P, Gibert M, Popoff MR, Mart\u00edn-Satu\u00e9 M (2004) Effect of epsilon toxin\u2013GFP on MDCK cells and renal Tubules in vivo. J Histochem Cytochem 52:931\u2013942","journal-title":"J Histochem Cytochem"},{"key":"1069_CR39","doi-asserted-by":"crossref","unstructured":"Stiles BG, Barth G, Barth H, Popoff MR (2013) Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man? Toxins (Basel) 5:2138\u20132160","DOI":"10.3390\/toxins5112138"},{"key":"1069_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.provac.2011.10.006","volume":"5","author":"WS Stokes","year":"2011","unstructured":"Stokes WS, Brown K, Kulpa-Eddy J, Srinivas G, Halder M, Draayer H, Galvin J, Claassen I, Gifford G, Woodland R (2011) Improving animal welfare and reducing animal use for veterinary vaccine potency testing: state of the science and future directions. Procedia in Vaccinology 5:84\u2013105","journal-title":"Procedia in Vaccinology"},{"key":"1069_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-021-02757-5","volume":"17","author":"Q Wu","year":"2021","unstructured":"Wu Q, Lin Z, Wu J, Qian K, Shao H, Ye J, Qin A (2021) Peptide enzyme-linked immunosorbent assay (pELISA) as a possible alternative to the neutralization test for evaluating the immune response to IBV vaccine. BMC Vet Res 17:1\u20137","journal-title":"BMC Vet Res"},{"key":"1069_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bsheal.2019.09.004","volume":"1","author":"W Xin","year":"2019","unstructured":"Xin W, Wang J (2019) Clostridium perfringens epsilon toxin: toxic effects and mechanisms of action. Biosafety and Health 1:71\u201375","journal-title":"Biosafety and Health"}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-025-01069-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11626-025-01069-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-025-01069-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:38:20Z","timestamp":1756993100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11626-025-01069-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1007\/s11626-025-01069-4","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"type":"print","value":"1071-2690"},{"type":"electronic","value":"1543-706X"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}